CO5140100A1 - Composiciones estimulantes del crecimiento mejoradas el crecimiento del ganado - Google Patents

Composiciones estimulantes del crecimiento mejoradas el crecimiento del ganado

Info

Publication number
CO5140100A1
CO5140100A1 CO99069032A CO99069032A CO5140100A1 CO 5140100 A1 CO5140100 A1 CO 5140100A1 CO 99069032 A CO99069032 A CO 99069032A CO 99069032 A CO99069032 A CO 99069032A CO 5140100 A1 CO5140100 A1 CO 5140100A1
Authority
CO
Colombia
Prior art keywords
growth
livestock
improved
release
stimulating compositions
Prior art date
Application number
CO99069032A
Other languages
English (en)
Inventor
Shih Chung
Kennedy Thomas J
Peter James Knight
Jesse Shao Zezhi
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CO5140100A1 publication Critical patent/CO5140100A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un estimulante del crecimiento y del peso mejorado para animales domesticados como ser ganado, cerdos y ovejas está compuesto por un agente anabólico que es administrado subcutáneamente en la forma de una formulación de implante de liberación dual. Los aumentos incrementados son particularmente mejorados cuando se administra zeranol en una formulación de liberación inmediata y de liberación controlada que permite una inyección de dosificación de una vez.
CO99069032A 1998-11-04 1999-11-02 Composiciones estimulantes del crecimiento mejoradas el crecimiento del ganado CO5140100A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
CO5140100A1 true CO5140100A1 (es) 2002-03-22

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99069032A CO5140100A1 (es) 1998-11-04 1999-11-02 Composiciones estimulantes del crecimiento mejoradas el crecimiento del ganado

Country Status (11)

Country Link
AR (1) AR025133A1 (es)
AU (1) AU777393B2 (es)
BR (2) BR9914996A (es)
CA (1) CA2348841C (es)
CO (1) CO5140100A1 (es)
CR (1) CR6351A (es)
MY (1) MY134868A (es)
PE (1) PE20001092A1 (es)
TW (1) TWI250027B (es)
WO (1) WO2000025743A2 (es)
ZA (1) ZA200103494B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4000688A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
EP4001288A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
EP4001289B1 (en) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of trenbolone and/or trenbolone acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
CA2348841A1 (en) 2000-05-11
BRPI9914996B8 (pt) 2021-07-06
AR025133A1 (es) 2002-11-13
BR9914996A (pt) 2001-07-10
WO2000025743A3 (en) 2000-08-24
AU777393B2 (en) 2004-10-14
CA2348841C (en) 2007-04-17
WO2000025743A2 (en) 2000-05-11
BRPI9914996A (pt) 2001-07-10
PE20001092A1 (es) 2000-10-31
ZA200103494B (en) 2002-07-30
BRPI9914996B1 (pt) 2011-11-01
TWI250027B (en) 2006-03-01
MY134868A (en) 2007-12-31
AU3096700A (en) 2000-05-22
CR6351A (es) 2003-11-20

Similar Documents

Publication Publication Date Title
MacEwen et al. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum
AR045142A1 (es) Composicion veterinaria masticable ductil de buen sabor
ES2344505T3 (es) Formulaciones antiparasitarias.
NI200500087A (es) Derivados 4-tetrazolyl-4 fenilpiperidina para el tratamiento del dolor
AR098251A2 (es) Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario
AU763614B2 (en) Pellet implant system for immediate and delayed release of antiparasitic drug
CO5140100A1 (es) Composiciones estimulantes del crecimiento mejoradas el crecimiento del ganado
CA2568641A1 (en) Sustained release composition
AR019579A1 (es) USO DE UN INICIADOR DE LA RESPUESTA SEXUAL DEL SISTEMA NERVIOSO CENTRAL PARA LA FABRICACIoN DE UNA COMPOSICIoN FARMACÉUTICA PARA LA NORMALIZACIoN DE LA CRONOMETRACIoN DE LA RESPUESTA SEXUAL O PARA LA PROFILAXIS O REDUCCIoN DE LA LESIoN TISULAR GENITAL EN MAMíFEROS
Cardinal et al. Drug delivery in veterinary medicine
ECSP993205A (es) Composiciones estimulantes del crecimiento mejoradas (caso aho948)
CA2806153C (en) Compositions for controlling heartworm infestation
Ebedes, H., Gandini, GC M & Burroughs The use of long-acting neuroleptics in impala (Aepyceros melampus)
US20050169966A1 (en) Growth promoting pharmaceutical implant
TH48412A3 (th) องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง
Vandamme et al. Long acting rumen drug delivery systems
Albright et al. Can anxiolytic medications induce long-term improvement in dogs with noise aversion?
Hooks et al. Fecal Egg Counts and Performance of Stocker Calves Treated with Various Anthelmintics
de Medeiros Feline Injection-Site Sarcoma Complete Remission After Treatment with Isopathic medicine: a Case Report
RU2259821C2 (ru) Способ пролонгированной химиопрофилактики пироплазмидозов (пироплазмоз, бабезиоз и тейлериоз) крупного рогатого скота
Carulla et al. Effect of the number of feedings and calcium gluconate on the behavior of rearing calves. preliminary results.
AR093734A1 (es) Un metodo para tratar la enfermedad de lyme
Brandao et al. 104 Physiologic and Innate Immunity Responses of Beef Heifers Supplemented with an Immunomodulatory Feed Ingredient during a Lipopolysaccharide Challenge.
Chambers et al. Dynamic crossed-pin fixation of a distal femoral growth plate fracture in a domestic rabbit (Oryctolagus cuniculus).
Alvarez et al. Grazing behaviour of Churra Tensina ewes managed under different alternatives in spring.